Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Phillips

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Biophysical Chemistry|January 25, 2011
The conformational effect of para-substituted C8-arylguanine adducts on the B/Z-DNA equilibriumVorasit Vongsutilers, Daniel J Phillips, Brian C Train, et al.
Vaccine|July 26, 2024
Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trialLucy R Williams, Katherine R W Emary, Daniel J Phillips, et al.
Biomacromolecules|April 4, 2017
Evaluation of the Antimicrobial Activity of Cationic Polymers against Mycobacteria: Toward Antitubercular MacromoleculesDaniel J Phillips, James Harrison, Sarah-Jane Richards, et al.
British Journal of Pharmacology|February 15, 2017
Identification of the anti-mycobacterial functional properties of piperidinol derivativesCollette S Guy, Esther Tichauer, Gemma L Kay, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Hybrid-Mobile Stroke Unit: Opening the Indication Spectrum for Stroke Mimics and BeyondKlaus Fassbender, Daniel J Phillips, Iris Q Grunwald, et al.
Nature Medicine|September 30, 2021
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionShuo Feng, Daniel J Phillips, Thomas White, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 27, 2020
Mobile Stroke Unit in the UK Healthcare System: Avoidance of Unnecessary Accident and Emergency AdmissionsIris Q Grunwald, Daniel J Phillips, David Sexby, et al.
Lancet (London, England)|April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trialKatherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Lancet (London, England)|February 22, 2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trialsMerryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Biophysical Chemistry|January 25, 2011
The conformational effect of para-substituted C8-arylguanine adducts on the B/Z-DNA equilibriumVorasit Vongsutilers, Daniel J Phillips, Brian C Train, et al.
Vaccine|July 26, 2024
Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trialLucy R Williams, Katherine R W Emary, Daniel J Phillips, et al.
Biomacromolecules|April 4, 2017
Evaluation of the Antimicrobial Activity of Cationic Polymers against Mycobacteria: Toward Antitubercular MacromoleculesDaniel J Phillips, James Harrison, Sarah-Jane Richards, et al.
British Journal of Pharmacology|February 15, 2017
Identification of the anti-mycobacterial functional properties of piperidinol derivativesCollette S Guy, Esther Tichauer, Gemma L Kay, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Hybrid-Mobile Stroke Unit: Opening the Indication Spectrum for Stroke Mimics and BeyondKlaus Fassbender, Daniel J Phillips, Iris Q Grunwald, et al.
Nature Medicine|September 30, 2021
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionShuo Feng, Daniel J Phillips, Thomas White, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 27, 2020
Mobile Stroke Unit in the UK Healthcare System: Avoidance of Unnecessary Accident and Emergency AdmissionsIris Q Grunwald, Daniel J Phillips, David Sexby, et al.
Lancet (London, England)|April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trialKatherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Lancet (London, England)|February 22, 2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trialsMerryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Pageof 3